🏅 FDA Orphan Designation

Horizant

gabapentin enacarbil

Manufacturer: Arbor Pharmaceuticals, LLC

Indicated for:

NON RARE IN EUROPE: Post-herpetic neuralgiaOrphanX-linked severe syndromic thoracic aortic aneurysm and dissection

FDA-Approved Indications (2)

NON RARE IN EUROPE: Post-herpetic neuralgiaOrphan Designation

Management of postherpetic neuralgia in adults.

X-linked severe syndromic thoracic aortic aneurysm and dissection

treatment of moderate-to-severe primary Restless Legs Syndrome (RLS) in adults

Population: adults

Indications & Usage

1 INDICATIONS AND USAGE HORIZANT is indicated for: treatment of moderate-to-severe primary Restless Legs Syndrome (RLS) in adults. ( 1.1 ) management of postherpetic neuralgia (PHN) in adults. ( 1.2 ) 1.1 Treatment of Restless Legs Syndrome HORIZANT ® is indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS) in adults. HORIZANT is not recommended for patients who are required to sleep during the daytime and remain awake at night. 1.2 Management of Postherpetic Neuralgia HORIZANT is indicated for the management of postherpetic neuralgia (PHN) in adults.

💙 Support Programs

View all →

Horizant

Azurity

Copay card ↗Apply ↗

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.